Sai Parenteral's

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0H9F01037
NSEID: SAIPARENT
BSEID: 544742
View on NSE | View on BSE

INR

423.75

-0.2 (-0.05%)

BSENSE

Apr 10

BSE+NSE Vol: 5.87 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Kwality Pharma

Shukra Pharma.

IOL Chemicals

Windlas Biotech

Morepen Labs.

Unichem Labs.

Solara Active

Hikal

Indoco Remedies

Panacea Biotec

Sai Parenteral's

Why is Sai Parenterals Ltd ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0

EBIT Growth (5y)

0

EBIT to Interest (avg)

2.71

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0

Sales to Capital Employed (avg)

0

Tax Ratio

28.14%

Dividend Payout Ratio

0

Pledged Shares

0

Institutional Holding

18.59%

ROCE (avg)

0

ROE (avg)

0

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

181

Industry P/E

32

Price to Book Value

20.51

EV to EBIT

90.58

EV to EBITDA

72.13

EV to Capital Employed

12.00

EV to Sales

15.64

PEG Ratio

NA

Dividend Yield

NA

ROCE (Latest)

13.24%

ROE (Latest)

11.32%

Loading Valuation Snapshot...

Technicals

Technical key factors

No Data found

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Loading Valuation Snapshot...